Publication & Citation Trends
Most Cited Works
Publications
241 total
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter PDF
Cited by 473
OpenAlex
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated <i>MGMT</i> promoter: An international randomized phase III trial PDF
Cited by 460
OpenAlex
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma PDF
Cited by 1,408
OpenAlex
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology PDF
Cited by 552
OpenAlex
Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells PDF
Cited by 337
OpenAlex
Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma
Cited by 148
OpenAlex
Research Topics
Glioma Diagnosis and Treatment
(130)
Brain Metastases and Treatment
(49)
CNS Lymphoma Diagnosis and Treatment
(42)
Lymphoma Diagnosis and Treatment
(29)
Cancer Immunotherapy and Biomarkers
(24)
Frequent Co-Authors
Affiliations
University of Iowa
Centre National de la Recherche Scientifique
Cleveland Clinic
Yale New Haven Hospital
Mayo Clinic